Author

Welti Annik

University Children's Hospital Zurich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

Amin AllalouiD· 1 shared Bernard CirauloiD· 1 shared Bleiker Tanja· 1 shared Dejana Versamento· 1 shared Dina Hochuli· 1 shared Levi Luca KoppiD· 1 shared Marc Thomas Schönholzer· 1 shared Martin BaumgartneriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amin AllalouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJul 23, 2026

MAP4K inhibition by the CNS penetrant inhibitor famlasertib restrains medulloblastoma dissemination without developmental toxicity

Marc Thomas Schönholzer, Meng-Syuan Lin, Shen Yan…·Martin Baumgartner

This study shows that famlasertib, a MAP4K inhibitor, reduces medulloblastoma cell invasion in vitro and in zebrafish models without causing developmental toxicity.

DOI 10.64898/2026.05.11.724200

zebrafishproteomics

𝕏 PostBluesky